News Alessandra Heinz

(1 - 5 von 5
)

evobrutinib relapsing multiple sclerosis (rms) update callMerck KGaA

www.merckgroup.com
— ALESSANDRA HEINZ. Assistant Investor Relations. + PATRICK BAYER. Institutional Investors — ALESSANDRA HEINZ. Assistant Investor Relations. + PATRICK BAYER. Institutional Investors ...

MERCK KGAA, DARMSTADT, GERMANY –EMD Group

www.emdgroup.com
— ALESSANDRA HEINZ. Assistant Investor Relations. + WEB: www — ALESSANDRA HEINZ. Assistant Investor Relations. + WEB: www ...

Evobrutinib (RMS) Update Call - webcast February 20, 2020, 1:00 CET |...

www.marketscreener.com
EVOBRUTINIB RELAPSING MULTIPLE SCLEROSIS UPDATE CALL Investor Relations Luciano Rossetti...

Performance Materials Strategy Updatemhjiajv.com

www.mhjiajv.com
— ALESSANDRA HEINZ. Assistant Investor Relations. + › corporate › investors

Q2 20 Analyst call, August 06, 2020, 2:00pm CET | MarketScreener

www.marketscreener.com
Top Line reflects COVID-19 impact, Bottom line well managed Merck KGaA, Darmstadt, Germany Q results...
+1